More Than Meets the Eye

Program Goals

Importance of Histology and Genotyping in NSCLC

Importance of Histology and Genotyping in NSCLC (cont)

CAP/IASLC Guidelines

Case Study 1

Case Study 1 (cont)

Treatment Selection in NSCLC: Tumor and Patient Considerations

Nab-Paclitaxel vs Solvent-Based Paclitaxel in Elderly Patients

Nivolumab: Checkmate 017

Ramucirumab: REVEL

Current Phase III Clinical Trials in Advanced Squamous Cell NSCLC (Selected)

Case Study 2: Non-squamous Pan-Negative NSCLC

Case Study 2: Biopsy Results

First-Line Treatment of Pan-Negative Non-squamous NSCLC

Emerging Agents for 2nd-line Treatment of Non-Squamous NSCLC

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)